Hirota Fujiki

3PUBLICATIONS
0CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 25, 2023
Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A.

Hirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe

|Oct 21, 2018
The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.

Hirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe

|Sep 25, 2017
Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.

Hirota Fujiki, Eisaburo Sueoka, Anchalee Rawangkan

Pageof 1

Frequent Collaborators